RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Clinical trials for RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted radiation attack on tough brain tumors in kids
Disease control Recruiting nowThis study is testing a drug called Lutathera in children and young adults (ages 4 to 39) with aggressive brain or spinal cord tumors that have come back or gotten worse after standard treatments. Lutathera is a targeted radiation therapy that seeks out and attaches to specific m…
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for kids with devastating brain tumors: trial tests flexible drug combinations
Disease control Recruiting nowThis trial is testing new drug combinations for children and young adults with aggressive brain tumors called diffuse midline gliomas (DMGs), which currently have very few treatment options. It uses a flexible 'platform' design to test different drug combinations, including ONC20…
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for kids with aggressive brain tumors: experimental drug trial opens
Disease control Recruiting nowThis early-stage trial is testing a new drug called CBL0137 in children and young adults (ages 1-21) whose solid tumors, brain tumors, or lymphoma have come back or stopped responding to standard treatments. The main goals are to find the safest dose and see if the drug can help …
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC